Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Strive raises capital to buy 2,624 Bitcoin in a record week, boosting holdings to 16,500 BTC.

Market News
29 May 2026
Crypto Briefing
View Source
Bullish
pluang ai news

Strive, Inc. raised capital through its preferred stock SATA to purchase about 2,624 Bitcoin in one week, doubling its previous weekly record. This aggressive buying increased its total Bitcoin holdings to roughly 16,500 BTC, valued at over $1.2 billion. The company’s strategy relies on Bitcoin maintaining or rising above its average acquisition cost of around $100,000 per coin, while paying investors a 13% dividend on SATA shares. Strive’s rapid accumulation highlights its unique model of funding Bitcoin purchases via preferred stock, positioning it among the largest corporate Bitcoin holders worldwide.

More News

YieldMax to close and liquidate four ETFs by June 18, 2026, focusing on stronger funds.

YieldMax to close and liquidate four ETFs by June 18, 2026, focusing on stronger funds.

YieldMax announced it will close and liquidate four ETFs—ABNY, DISO, FEAT, and FIVY—by June 18, 2026, following a portfolio review. The decision aims to concentrate resources on ETFs with higher investor demand and better market traction. Trading for...

Company Fundamentals
Bearish
22 minutes ago
Canborsa launches beta of first perpetual DEX for tokenized real-world assets with up to 20x leverage.

Canborsa launches beta of first perpetual DEX for tokenized real-world assets with up to 20x leverage.

Canborsa has launched the beta version of its decentralized exchange (DEX) on the Canton Network, enabling non-custodial perpetual trading of tokenized real-world assets like stocks, gold, oil, and cryptocurrencies with up to 20x leverage. The platfo...

Others
Bullish
22 minutes ago
Oculis' Phase 3 trials for OCS-01 in diabetic macular edema fail primary vision improvement endpoint.

Oculis' Phase 3 trials for OCS-01 in diabetic macular edema fail primary vision improvement endpoint.

Oculis announced that its Phase 3 DIAMOND trials for OCS-01 eye drops in diabetic macular edema did not meet the primary endpoint of improved visual acuity after 52 weeks. However, the treatment showed significant and lasting reduction in retinal thi...

Company Fundamentals
Bearish
1 hour ago
Allied Gold receives key regulatory approvals, extends deal deadline with Zijin Gold to July 29, 2026.

Allied Gold receives key regulatory approvals, extends deal deadline with Zijin Gold to July 29, 2026.

Allied Gold Corporation announced that Zijin Gold has received approval under the Investment Canada Act for its proposed acquisition of Allied Gold. This approval completes the Canadian regulatory process for the transaction. The deal has also cleare...

Company Fundamentals
Bullish
1 hour ago
Kentucky First Federal Bancorp may resume quarterly dividends up to $0.10 per share after a special board meeting on July 28, 2026.

Kentucky First Federal Bancorp may resume quarterly dividends up to $0.10 per share after a special board meeting on July 28, 2026.

Kentucky First Federal Bancorp announced a special board meeting on July 28, 2026, to consider resuming quarterly dividends on its common stock, potentially up to $0.10 per share. The company has suspended dividends since November 2023, and no final ...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App